ARK 每周股评 – 7/17/2021


We share weekly commentaries with investors on stocks in our strategies that have appreciated or dropped more than 15% in a day during the course of the week. We hope you find this commentary useful.

Recursion Pharmaceuticals (RXRX)
-19%Recursion Pharmaceuticals (RXRX), a pioneering drug-discovery company at the interface between artificial intelligence and biology, traded down approximately 19% on Wednesday during a broad market selloff that hit biotech particularly hard. As one of its IPO investors, we feel confident that Recursion's drug-discovery and optimization engine, Recursion OS, is second to none in the therapeutics industry. Recursion's platform is a low-latency feedback loop that incorporates wet-lab cell experiments, novel computer vision techniques (phenomics), and powerful AI systems to inference therapeutic candidates in the chemical space.

注: Recursion Pharmaceuticals (RXRX) 是一家位于人工智能和生物学之间的先锋药物发现公司,在周三大盘下跌期间,交易量下降了约19%,这对生物技术的打击尤为严重。作为其IPO投资者之一,我们确信Recursion的药物发现和优化引擎Recursion OS在治疗行业是首屈一指的。Recursion的平台是一个低延迟的反馈回路,它结合了湿式实验室细胞实验、新颖的计算机视觉技术(表型组学)和强大的人工智能系统来推断化学领域的候选治疗药物。
ZhongAn Online (6060 HK)
+16%ZhongAn Online (6060 HK) rallied 16% on Thursday after disclosing gross written premium data that indicated a 45% year over year increase. ZhongAn Online is an internet-based insurance underwriter and distributor in China. Its core insurance products include health, auto, digital lifestyle including ecommerce returns, and consumer finance.

注: 众安在线(6060 HK)周四上涨16%,此前披露的总承保保费数据显示同比增长45%。众安在线是中国一家基于互联网的保险承保人和分销商。其核心保险产品包括健康、汽车、数字生活方式(包括电商退货)和消费金融。


上一篇 2021年7月19日 上午9:10
下一篇 2021年7月19日 上午9:23